IL-17

      TNFi cycling vs. switching to IL-17Ai?
      Dr @AlexisOgdie et al from CorEvitas registry:
      PsA & axSpA cohort - switche

      sheila RHEUMarampa

      9 months 2 weeks ago
      TNFi cycling vs. switching to IL-17Ai? Dr @AlexisOgdie et al from CorEvitas registry: PsA & axSpA cohort - switchers (TNFi to IL17i) had greater improvements in cDAPSA & BASDAI vs. cyclers (2nd TNF) Not stat significant but offers alternative Tx options @RheumNow #ACR24 abs585 https://t.co/8m347BRM75
      Summary of treatments in psoriatic arthritis #PsA @RheumNow #ACR24 https://t.co/EybzRCPLtA

      Antoni Chan MD (Prof) synovialjoints

      9 months 2 weeks ago
      Summary of treatments in psoriatic arthritis #PsA @RheumNow #ACR24 https://t.co/EybzRCPLtA
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Catch up on Conference Podcasts

      ×